Pushing bounds of cancer research

After developing a 20-year career in precision health care at world-renowned pharmaceutical companies, including Cambridge, Mass.-based Helicos Biosciences and Claritas Genomics, Patrice M. Milos decided to open Medley Genomics to push cancer research even further. “While we’re learning more about cancer, we’re still dealing with an often fatal disease,” said the president of the Providence-based

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber